Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib.

MLA

Funo, Takumi, et al. “Conversion Surgery for BRCA-Mutated Pancreatic Ductal Adenocarcinoma with Liver Metastasis Treated with Platinum-Based Chemotherapy Followed by Olaparib.” Surgical Case Reports, vol. 10, no. 1, July 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s40792-024-01975-x.

APA

Funo, T., Hashimoto, D., Yamaki, S., Matsumura, K., Miyazaki, H., Matsui, Y., Tsybulskyi, D., Sang, N. T., Yaolin, X., & Satoi, S. (2024). Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib. Surgical Case Reports, 10(1), 1–7. https://doi.org/10.1186/s40792-024-01975-x

Chicago

Funo, Takumi, Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuki Matsui, Denys Tsybulskyi, Nguyen Thanh Sang, Xu Yaolin, and Sohei Satoi. 2024. “Conversion Surgery for BRCA-Mutated Pancreatic Ductal Adenocarcinoma with Liver Metastasis Treated with Platinum-Based Chemotherapy Followed by Olaparib.” Surgical Case Reports 10 (1): 1–7. doi:10.1186/s40792-024-01975-x.